自身免疫性肝炎的影像学研究进展

摘要/Abstract

摘要： 自身免疫性肝炎(autoimmune hepatitis,AIH)是一种病因未明的慢性肝病,目前尚无特征性的诊断标志物,其诊断主要依靠组织学、临床特征及实验室检查等,肝活检仍是金标准,且AIH患者肝组织学评估已成为监测患者疗效及停药指标,但其有创性、术后并发症重等缺点,导致患者依从性较差。无创影像学检查在AIH患者中应用较少,且目前尚未发现特征性的影像学表现,但近年来影像学发展迅速,越来越多的影像学检查用于弥漫性肝病(如病毒性肝炎)评估,现对自身免疫性肝炎影像学应用进展做一个概述。

韩笑, 马红. 自身免疫性肝炎的影像学研究进展[J]. 肝脏, 2024, 29(3): 363-366.

参考文献

[1] Lv T, Li M, Zeng N, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population[J]. J Gastroenterol Hepatol, 2019, 34(10): 1676-1684.
[2] Montano-Loza A J, Thandassery R B, Czaja A J. Targeting hepatic fibrosis in autoimmune hepatitis[J]. Dig Dis Sci, 2016, 61(11): 3118-3139.
[3] Rockey D C, Caldwell S H, Goodman Z D, et al. Liver biopsy[J]. Hepatology, 2009, 49(3): 1017-1044.
[4] Sandrin L, Fourquet B, Hasquenoph J M, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis[J]. Ultrasound Med Biol, 2003, 29(12): 1705-1713.
[5] Xu Q, Sheng L, Bao H, et al. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis[J]. J Gastroenterol Hepatol, 2017, 32(3): 639-644.
[6] Raizner A, Shillingford N, Mitchell P D, et al. Hepatic inflammation may influence liver stiffness measurements by transient elastography in children and young adults[J]. J Pediatr Gastroenterol Nutr, 2017, 64(4): 512-517.
[7] Yan Y l, Xing X, Wang Y, et al. Clinical utility of two-dimensional shear-wave elastography in monitoring disease course in autoimmune hepatitis-primary biliary cholangitis overlap syndrome[J]. World J Gastroenterol, 2022, 28(18): 2021-2033.
[8] Xing X, Yan Y, Shen Y, et al. Liver fibrosis with two-dimensional shear-wave elastography in patients with autoimmune hepatitis[J]. Expert Rev Gastroenterol Hepatol, 2020, 14(7): 631-638.
[9] Janik M K, Kruk B, Szczepankiewicz B, et al. Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis[J]. Liver Int, 2021, 41(2): 348-356.
[10] Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis[J]. Liver Int, 2013, 33(8): 1138-1147.
[11] Righi S, Fiorini E, De Molo C, et al. ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study[J]. J Ultrasound, 2012, 15(4): 226-231.
[12] Efe C, Gungoren M S, Ozaslan E, et al. Acoustic radiation force impulse (ARFI) for fibrosis staging in patients with autoimmune hepatitis[J]. Hepatogastroenterology, 2015, 62(139): 670-672.
[13] Goertz R S, Gabmann L, Strobel D, et al. Acoustic radiation force impulse (ARFI) elastography in autoimmune and cholestatic liver diseases[J]. Ann Hepatol, 2019, 18(1): 23-29.
[14] Garg D, Nagar A, Philips S, et al. Immunological diseases of the pancreatico-hepatobiliary system: update on etiopathogenesis and cross-sectional imaging findings[J]. Abdom Imaging (NY), 2012, 37(2): 261-274.
[15] Qayyum A, Graser A, Westphalen A, et al. CT of benign hypervascular liver nodules in autoimmune hepatitis[J]. AJR Am J Roentgenol, 2004, 183(6): 1573-1576.
[16] Yasui S, Fujiwara K, Okitsu K, et al. Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure[J]. Hepatol Res, 2012, 42(1): 42-50.
[17] Fujiwara K, Fukuda Y, Seza K, et al. Analysis of non-severe acute onset autoimmune hepatitis according to the presence of radiological heterogeneity[J]. Hepatol Res, 2022, 52(9): 804-810.
[18] Sahni V A, Raghunathan G, Mearadji B, et al. Autoimmune hepatitis: CT and MR imaging features with histopathological correlation[J]. Abdom Imaging, 2010, 35(1): 75-84.
[19] Bilaj F, Hyslop W B, Rivero H, et al. MR imaging findings in autoimmune hepatitis: correlation with clinical staging[J]. Radiology, 2005, 236(3): 896-902.
[20] Banerjee R, Pavlides M, Tunnicliffe E M, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease[J]. J Hepatol, 2014, 60(1): 69-77.
[21] Pavlides M, Banerjee R, Sellwood J, et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease[J]. J Hepatology, 2016, 64(2): 308-315.
[22] Tafur M, Cheung A, Menezes R J, et al. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography[J]. Eur Radiol, 2020, 30(7): 3735-3747.
[23] Mesropyan N, Kupczyk P, Dold L, et al. Non-invasive assessment of liver fibrosis in autoimmune hepatitis: diagnostic value of liver magnetic resonance parametric mapping including extracellular volume fraction[J]. Abdom Radiol (NY), 2021, 46(6): 2458-2466.
[24] Harrison S A, Dennis A, Fiore M M, et al. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial[J]. PloS One, 2018, 13(9): e0203054.
[25] Pavlides M, Banerjee R, Tunnicliffe E M, et al. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity[J]. Liver Int, 2017, 37(7): 1065-1073.
[26] Eddowes P J, Mcdonald N, Davies N, et al. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2018, 47(5): 631-644.
[27] Mcdonald N, Eddowes P J, Hodson J, et al. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study[J]. Sci Rep, 2018, 8(1): 9189.
[28] Blake L, Duarte R V, Cummins C. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging[J]. BMJ Open, 2016, 6(9): e010507.
[29] Janowski K, Shumbayawonda E, Dennis A, et al. Multiparametric MRI as a noninvasive monitoring tool for children with autoimmune hepatitis[J]. J Pediatr Gastroenterol Nutr, 2021, 72(1): 108-114.
[30] Janowski K, Shumbayawonda E, Cheng L, et al. Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease[J]. Sci Rep, 2021, 11(1): 15261.
[31] Dillman J R, Tkach J A, Gandhi D, et al. Relationship between magnetic resonance imaging spleen T1 relaxation and other radiologic and clinical biomarkers of liver fibrosis in children and young adults with autoimmune liver disease[J]. Abdom Radiol (NY), 2020, 45(11): 3709-3715.